Ocular Pharmacology Flashcards

1
Q

lots of challenges to treat the eye

A

Lack of penetration
Topical drugs require frequent admin
Long duration of therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drug absorption

A

Major barriers that change w topical or systemic administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

drug absorption - topical

A

No problem for superficial infection - deeper is concerning physiological barriers
- tear turn over
- drainage out nasolacrimal ducts
- blinking
All decrease contact time of drug and eye

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anatomic barriers for deeper eye absorption

A

Multiple layers - lipophilic layers for epithelium and endothelium but hydrophilic in stroma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Topical drug absorption

A

Lipophilic, unionized, low MW administered frequently @ high doses will reach greater ocular concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Systemic absorption

A

Blood-aqueous and retinal barriers
- non fenestrated capillaries
- tight junctions
- p-glycoprotein efflux pumps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Systemic drug absorption

A

Lipophilic, unionized, low MW drugs w minimal protein binding that reach high systemic concentrations will reach greater ocular concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Inflammation and absorption

A

Inflammation increases drug absorption due to broken down blood ocular barrier
Ideally choose a drug that will have good penetration without factoring in inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ocular PK

A

Drug distribution through vitreous humor takes a long time
Drug probably wont be metabolized in the eye
Drainage /elimination through the chamber angle and is often slow. High /frequent dosage+ slow drainage = better chances at reaching high concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Routes of admin

A

Depends on location of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Systemic administration

A

Appropriate for posterior segment, endophthalmitis, orbital tissues
Also for anterior segment, corneal stroma - depends on degree of inflammation
Systemic is not ideal for corneal surface/conjunctiva

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antibacterial systemic admin

A

Lipophilic - minocycline, enrofloxaxin, chloramphenicol, macrolides, trimethoprima-sulfa combo
Hydrophilic - B lactams, aminoglycosides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Systemic admin for antifungals

A

Fluconazole, voriconazole
Itraconazole XX - too lipophilic and will get stuck in stroma
Antivirals - all hydrophilic should be treated topically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

topical admin

A

Corneal surface/conjunctiva disease
Lipophilic drugs are better for penetrating intact cornea
Not preferred for posterior segment disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Methods to increase topical drugs absorption/efficacy

A

Increased drug concentration in formula
Increase volume admin
Increase dose frequency***
Decrease corneal thickness
Use specialized formulations
Increase contact time
Stick needle into eye - XX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Increasing concentration of drug in formulation

A

Will increase absorption across the cornea up to a certain dose - also limited by surface area

17
Q

Increase drug absorption of topical admin across cornea

A

Decrease corneal thickness
Higher penetration w corneal ulceration
Alter drug formations
Increase drug contact time
Solutions vs ointments
Subconjunctival infections - steroids, amp b
By pass barriers ^^

18
Q

Topical antibiotics

A

Polymyxin B
Bacitracin
Gramicidin

19
Q

Antifungal formulations

A

Natamycin
Voriconazole
Amp B
Trifluridine & idozuridine - herpes keratitis

20
Q

Polymyxin B

A

Disrupt bacterial cell membrane by interacting w phospholipids - cell wall inhibitor, exclusively Gram Neg
Includes cloistin - Polymyxin E - topical or Endotoxemia but can cause dose dependent nephrotoxic

21
Q

Polymyxin prevention /mechanism

A

Binds to lipid end of chain and prevents endotoxic activities

22
Q

Bacitracin

A

Topical - not absorbed orally
Disrupts cell wall and peptidoglycan synthesis
Gram positives and negs

23
Q

Gramicidin

A

So similar to bacitracin

24
Q

Combo products for topicals

A

Polymyxin B, neomycin
Bacitracin, Gramicidin
All considered “triple antibiotic ointment”
Check for steroids**

25
Q

Do not use steroids for

A

Corneal ulcerations **

26
Q

Antifungal formations for eyes

A

Miconazole- azole antifungal, compounded
Nystatin - not used
Itraconazole - compounded in 30% DMSO
Natamycin - only FDA approved
Voriconazole - injectable formulation given topically

27
Q

Natamycin

A

Polyene antifungal similar to amp B
Best spectrum against filamentous fungi - aspergillus, fusarium* common causes of fungal keratitis
Does not penetrate intact cornea
- Natamycin for corneal fungal infection
- voriconazole for stromal or deeper

28
Q

Fungal keratitis

A

Voriconazole - good spectrum for aspergillus, fusarium
Formulation stable for 30d after reconstitution
*sterile technique

29
Q

Amp B

A

Subconjunctivally infected for refractory infections
- fusarium
Can be irritating and cause conjunctiva tissues to slough off

30
Q

Viral keratitis

A

Herpes* cats & horses
Trifluridine & idozuridine
Virostatic = no effect of latent viral particles
Helpful in clearing episodes not infection